The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist-Reference-Cited by-同舟云学术

The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist

Published:1991-04 Issue:3 Volume:196 Page:299-305
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Takemi Fukuda,Michihide Setoguchi,Ken-ichi Inaba,Hidenori Shoji,Tetsuya Tahara

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. GR38032F, a novel 5-HT3 receptor antagonist, can abolish emesis induced by cyclophosphamide or radiation in the ferrets;Andrews;Br. J. Pharmacol.,1987

2. Neuropharmacology of emesis induced by anti-cancer therapy;Andrews;Trends Pharmacol. Sci.,1988

3. The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL43694;Bermudez;Br. J. Cancer,1988

4. Characterization of the binding of 3H-SCH23390, a selective D-1 receptor antagonist ligand, in rat striatum;Billard;Life Sci.,1984

5. Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5-HT3antagonist;Cassidy;Br. J. Cancer,1988

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hearing loss drug discovery and medicinal chemistry: Current status, challenges, and opportunities;Progress in Medicinal Chemistry;2022

2. Recent advances with 5‐HT3modulators for neuropsychiatric and gastrointestinal disorders;Medicinal Research Reviews;2020-03

3. Quaternary salts derived from 3-substituted quinuclidine as potential antioxidative and antimicrobial agents;Open Chemistry;2017-12-19

4. Design and Synthesis of Novel 2-Hydroxy-1,4-Benzoxazine Derivatives through Three-Component Petasis Reaction Catalysed by Pyridinium Toluene-Sulphonate;Journal of Chemical Research;2016-08

5. Design and validation of a homogeneous time-resolved fluorescence cell-based assay targeting the ligand-gated ion channel 5-HT3A;Analytical Biochemistry;2015-09